Tesamorelin/Ipamorelin Blend 5mg/5mg Peptides
Purpose-built for rigorous GH-pathway investigations, this balanced dual-peptide formulation supports precise, repeatable research outcomes.
The Tesamorelin/Ipamorelin blend is supplied as a peptide lyophilized vial for laboratory use, offering a clean, unflavored format designed for controlled handling. As a GH peptide blend, it combines two well-characterized research peptides in a single vial with a total strength of 10mg per vial (5mg/5mg). The lyophilized presentation is engineered for stability during storage and reliable reconstitution under appropriate laboratory conditions.
- 5mg Tesamorelin – A growth hormone–releasing hormone analog commonly studied for its role in modulating pituitary signaling dynamics and GH-related pathways in controlled models.
- 5mg Ipamorelin – A selective growth hormone secretagogue investigated for receptor-specific activity and GH pulse characteristics with minimal off-target interaction in comparative assays.
In practice, the lyophilized cake is formulated for straightforward laboratory handling and clean dissolution with an appropriate sterile diluent. Researchers will appreciate the streamlined single-vial format, clear component labeling, and lot identification that supports traceability. The unflavored, compositionally simple profile is suited for method development, assay standardization, and side-by-side comparisons of GH-pathway variables where blend consistency matters. Storage and handling align with standard peptide laboratory practices: protect from excessive heat or light, minimize repeated freeze-thaw exposure, and follow established sterile technique during all manipulations.
Peptide Scientific Labs prioritizes quality at every step, from careful sourcing to controlled manufacturing and meticulous lot verification. Each batch is produced in the USA under stringent quality systems and released only after testing for identity, purity, and consistency. Lot-specific documentation is maintained to support internal QA review and research traceability. This product is intended strictly for laboratory research use only and is not for human consumption, clinical use, or veterinary use. By emphasizing purity, consistency, and transparent quality standards, Peptide Scientific Labs provides a dependable option for investigators who require confidence in their GH peptide materials.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is TESA/IPA Blend typically studied for?
Researchers generally study this combination for growth-hormone pulse support, IGF-1-related signaling, and body-composition or recovery-oriented endocrine models. The useful nuance for an FAQ is that blends like this are chosen for pathway complementarity, but study relevance still depends on the exact dose ratio disclosed by the vendor.
What is TESA/IPA Blend?
TESA/IPA Blend combines Tesamorelin, a GHRH analog, with Ipamorelin, a ghrelin-receptor agonist. The purpose of the blend is to bring together two different upstream signals that can influence endogenous growth-hormone release. On a site page, it should be described as a research blend for GH-axis and endocrine studies only.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
